Jennifer Hamilton


Jennifer Hamilton,

Senior Director, New Ventures

Jennifer Hamilton is the Senior Director, New Ventures at Johnson & Johnson Innovation.
Formerly, Jennifer was an Advisor to Johnson & Johnson Innovation where she was responsible for scouting opportunities in Canada.  Previously, Jennifer was an Advisor to Johnson & Johnson’s Corporate Office of Science and Technology (COSAT) where she maintained similar responsibilities.
Prior to joining J&J, Jennifer spent 10 years as Venture Partner at UK-based Nomura Phase4 Ventures, an international life sciences fund.  Previously, she was an Investment Director with Rothschild Asset Management which managed two global publicly traded funds and lead investments in Angiotech, AnorMed, Immgenics, Inflazyme and TerraGen.  She has worked as an advisor to early and late-stage companies, venture funds and pension funds giving financing, business development and M&A advice.
Jennifer has an MSc and a PhD in Experimental Pathology/Lipid Metabolism from the University of British Columbia and a BSc from the University of Guelph.


Neomed (Montreal)
7171 Frederick-Banting
Montreal, Quebec, CANADA H4S 1Z9
(514) 367 1212
Your web browser is out of date. For the most optimal experience, please upgrade to the newest version of IE. Thank You.